These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 1283187

  • 21. The effects of the calcium antagonist amlodipine on blood pressure and platelet aggregation in hypertensive patients.
    Hernández R, Carvajal AR, Armas-de Hernández MJ, Guerrero-Pajuelo J, Armas-Padilla MC, Barragán O, Machado-de Alvarado I.
    Postgrad Med J; 1991; 67 Suppl 5():S38-40. PubMed ID: 1839438
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Antihypertensive action of various talinolol dosages after four week's treatment in comparison with placebo].
    Weigmann I, Terhaag B, Wierich W, Herrmann WM.
    Arzneimittelforschung; 1998 Mar; 48(3):240-4. PubMed ID: 9553680
    [Abstract] [Full Text] [Related]

  • 27. [Effect of nilvadipine on diurnal blood pressure profile. Use of a new calcium channel blocker in mild to intermediate hypertension].
    Keck M, Quitzdorff G.
    Fortschr Med; 1992 Aug 30; 110(24):444-6. PubMed ID: 1398392
    [Abstract] [Full Text] [Related]

  • 28. Nifedipine gastrointestinal therapeutic system in the treatment of hypertension. Results of a multicenter trial. The Modern Approach to the Treatment of Hypertension (MATH) Study Group.
    Krakoff LR, Bravo EL, Tuck ML, Friedman CP.
    Am J Hypertens; 1990 Dec 30; 3(12 Pt 2):318S-325S. PubMed ID: 2078318
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Acute and short-term effects of new calcium antagonist in hypertension.
    Burris JF, Notargiacomo AV, Papademetriou V, Freis ED.
    Hypertension; 1982 Dec 30; 4(3 Pt 2):32-5. PubMed ID: 7068206
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Ambulatory blood pressure monitoring in elderly hypertensives treated with the new calcium antagonist, nilvadipine.
    Tsuchihashi T, Tsukashima A, Matsumura K, Abe I, Tominaga M, Nakao Y, Kobayashi K, Fujishima M.
    Eur J Clin Pharmacol; 1991 Dec 30; 41(3):255-7. PubMed ID: 1748143
    [Abstract] [Full Text] [Related]

  • 36. Demonstration of safety in Alzheimer's patients for intervention with an anti-hypertensive drug Nilvadipine: results from a 6-week open label study.
    Kennelly SP, Abdullah L, Paris D, Parish J, Mathura V, Mullan M, Crawford F, Lawlor BA, Kenny RA.
    Int J Geriatr Psychiatry; 2011 Oct 30; 26(10):1038-45. PubMed ID: 21905098
    [Abstract] [Full Text] [Related]

  • 37. [24-hour blood pressure decrease with nifedipine with a new galenic action].
    Bühler G, Rosenthal JR, Santak J, Stephanos S, Wadepuhl M.
    Fortschr Med; 1992 Feb 10; 110(4):57-8, 61-2. PubMed ID: 1568692
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Investigation on the blood pressure-independent nephroprotective effect of nilvadipine in type 2 diabetics].
    Dohmen W.
    MMW Fortschr Med; 2008 Jan 17; 149 Suppl 4():167-71. PubMed ID: 18402242
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.